Long COVID Trial, Recruiting NCT07661862 Sponsor: University of Tasmania Condition: Long COVID
Back to Long Covid

Long COVID Trial, Recruiting

NCT07661862
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 40 years of age or older
  • Your ability to do physical activities has been measured as lower than expected for your age (using a specific questionnaire called the DASI)
  • You have previously had COVID-19 (the trial will note whether you were admitted to hospital for it)
  • You are currently experiencing fatigue, shortness of breath, or chest pain
  • You are eligible for Medicare
  • You are able and willing to sign a consent form, can communicate clearly with the research team, and can show you understand the study by explaining it back to them

Who may not be able to join:

  • You are unable to sign or provide written consent to take part in the study
  • You are already taking part in another research trial where receiving a randomly assigned treatment would not be acceptable
  • You have a physical mobility problem that would affect your ability to exercise
  • You have a history of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
  • You have a known significant heart valve problem, or a history of heart failure that significantly limits your daily activities (confirm with trial site)
  • You have a condition (including cancer or pregnancy) where your life expectancy is less than 12 months, or any other medical condition that the lead researchers feel makes it unsuitable for you to join the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +61 03 8532 1833

Australian sites

Menzies Insititute for Medical Research, Hobart, Tasmania
+61 03 8532 1833
Baker Heart and Diabetes Institute, Melbourne, Victoria
+61385321550

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Tasmania
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 April 2029

Where this trial is recruiting

🇦🇺 Australia

2 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Changes in 6-min walk distance (6MWD) at 6 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov